○Hiroya Naruse1, Hiroyuki Ishiura1, Jun Mitsui1,2, Yuji Takahashi3, Jun Goto4, Shoji Tsuji2,5, Tatsushi Toda1 (1.Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 2.Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, 3.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, 4.Department of Neurology, International University of Health and Welfare Mita Hospital, 5.Institute of Medical Genomics, International University of Health and Welfare)
Session information
[held on paper]English Poster Session
[Pe-24] English Poster Session 24
Motor neuron disease (basic research 2)
○Makoto Sainouchi1, Hidetomo Tanaka1, Hiroshi Shimizu1, Takuya Mashima2, Tomohiko Ishihara3, Takao Fukushima4, Kunihiko Makino4, Osamu Onodera3, Akiyoshi Kakita1 (1.Department of Pathology, Brain Research Institute, Niigata University, Japan, 2.Department of Neurology, Tsubame Rosai Hospital, 3.Department of Neurology, Brain Research Institute, Niigata University, 4.Department of Neurology, Niigata Prefectural Shibata Hospital)
○Mikiko Tada1, Hiroshi Doi1, Shingo Ikeda1, Shunta Hashiguchi1, Atsuko Katsumoto1, Misako Kunii1, Keita Takahashi1, Koyano Shigeru1,2, Hideyuki Takeuchi1, Fumiaki Tanaka1 (1.Dept. of Neurology and Stroke medicine, Yokohama City University Graduate School of Medicine, Japan, 2.Dept. of Neurology, Yokohama Minami Kyousai Hospital, Yokohama, Japan)
○Yoshiaki Nakayama1, Kazumi Tsuji1, Takashi Ayaki2, Fuminori Tokunaga3, Hidefumi Ito1 (1.Department of Neurology, Wakayama Medical University, Japan, 2.Department of Neurology, Faculty of Medicine, Kyoto University Graduate School of Medicine, 3.Department of Pathobiochemistry, Graduate School of Medicine, Osaka City University)
○Shintaro Tsuboguchi1, Yuka Nakamura2, Tomohiko Ishihara1,3, Taisuke Kato3, Akihide Koyama4, Tokiharu Sato2, Yutaka Yoshida5, Masaki Ueno2, Osamu Onodera1,3 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, 3.Department of Molecular Neuroscience, Brain Research Institute, Niigata University, 4.Division of Legal Medicine, Graduate School of Medicine and Dental Sciences, Niigata University, 5.Burke Neurological Institute)
○Yuichi Riku1,2, Akio Akagi1, Maya Mimuro1, Hiroaki Miyahara1, Yasushi Iwasaki1, Masahisa Katsuno2, Gen Sobue3, Mari Yoshida1 (1.Inst. for Medical Science of Aging, Aichi Med. Univ., Japan, 2.Dept. of Neurology, Nagoya Univ., Japan, 3.Aichi Med. Univ.)
○Kensuke Ikenaka1, Shinsuke Ishigaki2, Seiichi Nagano1, Gen Sobue3,4, Hideki Mochizuki1 (1.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 2.Department of Neurology, Nagoya University Graduate School of Medicine, 3.Aichi Medical University, Aichi, Japan, 4.Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine)
○Shuhei Kobashi1,2, Tomoya Terashima2, Shunya Kashiwagi2, Miwako Katagi2, Yuki Nakae2, Hideto Kojima2, Makoto Urushitani1 (1.Division of Neurology, Department of Medicine, Shiga University of Medical Science, Japan, 2.Department of Stem Cell Biology and Regenerative Medicine, Shiga University of Medical Science, Japan)
[Pe-24-9] CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in ALS mice
○Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Keita Takahashi, Atsuko Katsumoto, Misako Kunii, Mikiko Tada, Hiroshi Doi, Fumiaki Tanaka (Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan)